-
SCPS Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Scopus BioPharma (SCPS)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 362.10 k | 362.10 k | 362.10 k | 362.10 k | 362.10 k | 362.10 k |
Cash burn (monthly) | 346.46 k | 66.20 k | 976.29 k | 778.58 k | 336.41 k | 253.55 k |
Cash used (since last report) | 6.96 mm | 1.33 mm | 19.61 mm | 15.64 mm | 6.76 mm | 5.09 mm |
Cash remaining | -6.60 mm | -967.45 k | -19.25 mm | -15.28 mm | -6.39 mm | -4.73 mm |
Runway (months of cash) | -19.0 | -14.6 | -19.7 | -19.6 | -19.0 | -18.7 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.65 mm |
Total shares | 2.42 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
HCFP/Capital Partners 18B-1 | 1.35 mm | $3.71 mm |
SCPS/Strategic Capital Partners | 1.07 mm | $2.94 mm |